Search results for "Heart Failure"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2023
Evidence does not support giving renin angiotensin system inhibitors to all patients with stable CAD, review finds
For all primary outcomes studied, renin angiotensin system inhibitors reduced risk when compared to placebo but not when compared to active controls, a study found.
https://immattersacp.org/weekly/archives/2017/01/31/5.htm
31 Jan 2017
Drug interaction risks appear common among older patients being treated for epilepsy
Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018
LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use
Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018
Low-dose aspirin not associated with improved outcomes in heart failure without afib
A total of 5,450 patients were using low-dose aspirin at baseline, and of these, 3,840 were propensity-matched to nonaspirin users in a 1:1 ratio.
https://immattersacp.org/weekly/archives/2018/02/06/5.htm
6 Feb 2018
FDA approves heart failure drug, looks into antiseptic safety
This update covers a warning that sodium-glucose cotransporter-2 inhibitors can cause ketoacidosis, and approval of a drug that can reduce hospitalizations from worsening chronic heart failure.
https://immattersacp.org/archives/2015/07/fda.htm
1 Jul 2015
Rosuvastatin, atorvastatin compared on effectiveness, safety in industry-funded trial
Analysis of a randomized trial in South Korea found that patients randomized to rosuvastatin developed type 2 diabetes requiring medication at a rate of 7.2%, compared to 5.3% among those given atorvastatin.
https://immattersacp.org/weekly/archives/2023/10/24/4.htm
24 Oct 2023
Work toward equity in Black men's health
An expert discusses causes and effects of health disparities as well as ways to incorporate health equity into the practice of medicine.
https://immattersacp.org/archives/2023/07/work-toward-equity-in-black-mens-health.htm
1 Jul 2023
Aspirin does not appear to increase heart failure events in patients with reduced ejection fraction
No difference was seen between aspirin-treated and warfarin-treated patients for time to any first heart failure event or to first heart failure hospitalization.
https://immattersacp.org/weekly/archives/2017/08/08/4.htm
8 Aug 2017
MKSAP Quiz: Exacerbations of heart failure
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2018/03/13/3.htm
13 Mar 2018